Literature DB >> 7795076

Fatal sepsis due to a beta-lactamase-producing strain of Fusobacterium nucleatum subspecies polymorphum.

E J Goldstein1, P H Summanen, D M Citron, M H Rosove, S M Finegold.   

Abstract

A patient with Waldenström's macroglobulinemia was treated empirically with imipenem for sepsis related to oropharyngeal infection and responded within 24 hours. When blood cultures yielded Streptococcus agalactiae, the regimen was changed to ampicillin and gentamicin. The patient's condition rapidly deteriorated, and she died 3 days later. After her death, a strain of Fusobacterium nucleatum subspecies polymorphum producing beta-lactamase (PEN-Y; group 2a) was isolated from blood cultures. A literature review revealed increasingly frequent isolation of beta-lactamase-producing strains of F. nucleatum. Thus strains of F. nucleatum isolated from blood and other specimens from patients with serious infections should be tested for beta-lactamase production.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7795076     DOI: 10.1093/clinids/20.4.797

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  beta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children.

Authors:  E Könönen; A Kanervo; K Salminen; H Jousimies-Somer
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Lemierre's Syndrome.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.725

3.  Efficient gene transfer and targeted mutagenesis in Fusobacterium nucleatum.

Authors:  Susan Kinder Haake; Sean Yoder; Sharon Hunt Gerardo
Journal:  Plasmid       Date:  2005-08-22       Impact factor: 3.466

4.  Overwhelming pulmonary infection after a tobogganing accident.

Authors:  Ravinder Singh; Brian E Louie; William F Bennett; Christopher Allen; Tom Kelly; Christine H Lee
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-07       Impact factor: 2.471

5.  Genetic and biochemical characterization of FUS-1 (OXA-85), a narrow-spectrum class D beta-lactamase from Fusobacterium nucleatum subsp. polymorphum.

Authors:  Christine Voha; Jean-Denis Docquier; Gian Maria Rossolini; Thierry Fosse
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

6.  In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans.

Authors:  E J Goldstein; D M Citron; M Hudspeth; S Hunt Gerardo; C V Merriam
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

7.  Autoaggregation response of Fusobacterium nucleatum.

Authors:  Justin Merritt; Guoqing Niu; Toshinori Okinaga; Felicia Qi
Journal:  Appl Environ Microbiol       Date:  2009-10-16       Impact factor: 4.792

8.  An unusual case of Lemierre's syndrome presenting as pyomyositis.

Authors:  Nancy Crum-Cianflone; Richard Mayer
Journal:  Am J Med Sci       Date:  2008-06       Impact factor: 2.378

Review 9.  Osteomyelitis of a long bone due to Fusobacterium nucleatum and Actinomyces meyeri in an immunocompetent adult: a case report and literature review.

Authors:  Min Ji Lee; Young Eun Ha; Hye Yon Park; Jun Hee Lee; Yoon Jung Lee; Ki Sun Sung; Cheol-In Kang; Doo Ryeon Chung; Jae-Hoon Song; Kyong Ran Peck
Journal:  BMC Infect Dis       Date:  2012-07-20       Impact factor: 3.090

10.  Genome sequence of Fusobacterium nucleatum subspecies polymorphum - a genetically tractable fusobacterium.

Authors:  Sandor E Karpathy; Xiang Qin; Jason Gioia; Huaiyang Jiang; Yamei Liu; Joseph F Petrosino; Shailaja Yerrapragada; George E Fox; Susan Kinder Haake; George M Weinstock; Sarah K Highlander
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.